Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma
- PMID: 6166689
- DOI: 10.1016/0022-1759(81)90107-1
Double-decker rocket immunoelectrophoresis for direct quantitation of complement C3 split products with C3d specificities in plasma
Abstract
A double-decker rocket immunoelectrophoresis (DD-RIE) method for direct quantitation of complement split products with C3d determinants in human plasma is described. The usefulness of the DD-RIE method for monitoring C3 activation has been assessed and compared with conventional crossed immunoelectrophoresis (CIE) for C3c determination in a patient with iatrogenic septic shock and patients with rheumatoid arthritis. In contrast with CIE the DD-RIE method is quantitative by reference to a standard curve based on an internal reference C3d preparation and its sensitivity and assay capacity are superior to CIE. All reagents and antibody preparation are commercially available and the production of standards is easy. No overlapping was observed between C3d values in plasma from healthy persons and patients with active classical rheumatoid arthritis. The DD-RIE is highly suitable for routine use in laboratories of clinical immunology.
Similar articles
-
Comparative study of assays detecting complement activation. Complement-split product C3d (rocket immuno-electrophoresis) and C3d neodeterminants (ELISA).Scand J Clin Lab Invest. 1990 Jun;50(4):389-93. doi: 10.3109/00365519009091596. Scand J Clin Lab Invest. 1990. PMID: 1697427
-
A single step immunoelectrophoresis method for the quantitation of complement C3c in biological fluids.J Immunol Methods. 1983 Jun 10;60(3):277-88. doi: 10.1016/0022-1759(83)90286-7. J Immunol Methods. 1983. PMID: 6854034
-
Quantification of the C3d split products of human complement by a sensitive enzyme-linked immunosorbent assay.Scand J Immunol. 1985 Jun;21(6):607-13. doi: 10.1111/j.1365-3083.1985.tb01851.x. Scand J Immunol. 1985. PMID: 3895396
-
Detection of complement activation by counterimmunoelectrophoresis (CIE).J Immunol Methods. 1976;13(2):101-12. doi: 10.1016/0022-1759(76)90148-4. J Immunol Methods. 1976. PMID: 824368
-
Measurement of C3 conversion by ELISA estimation of neo-determinants on the C3d moiety.J Immunol Methods. 1986 Nov 20;94(1-2):1-6. doi: 10.1016/0022-1759(86)90207-3. J Immunol Methods. 1986. PMID: 2431062
Cited by
-
Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.Clin Exp Immunol. 2017 Feb;187(2):304-315. doi: 10.1111/cei.12890. Epub 2016 Nov 25. Clin Exp Immunol. 2017. PMID: 27784126 Free PMC article.
-
Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.Clin J Am Soc Nephrol. 2009 Aug;4(8):1312-6. doi: 10.2215/CJN.01090209. Epub 2009 Jun 25. Clin J Am Soc Nephrol. 2009. PMID: 19556379 Free PMC article.
-
Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.Rheumatol Int. 1985;5(3):97-101. doi: 10.1007/BF00541327. Rheumatol Int. 1985. PMID: 3892637
-
Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis.Clin Exp Immunol. 2002 Feb;127(2):310-5. doi: 10.1046/j.1365-2249.2002.01772.x. Clin Exp Immunol. 2002. PMID: 11876755 Free PMC article.
-
Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.Ann Rheum Dis. 1987 Jan;46(1):55-64. doi: 10.1136/ard.46.1.55. Ann Rheum Dis. 1987. PMID: 3492971 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous